Chemours Co is targeting net Leverage below 3.0x, versus 4.4x in Q2 2026, while pursuing Earnings growth and gross Debt reduction through future cycles. The plan matters because the presentation ties its 2027 pathway to improved cash flow, higher-value AI infrastructure markets and a stronger earnings foundation.
Key Highlights
- The presentation identifies net leverage below 3.0x, compared with 4.4x in the second quarter of 2026.
- Trailing-twelve-month free-cash-flow conversion reached approximately 30% through June 30, 2026.
- Chemours is targeting net leverage below 3.0x through future cycles.
Chemours Co (NYSE: CC) is targeting net leverage below 3.0x, compared with 4.4x in the second quarter of 2026, while pursuing earnings growth and gross debt reduction through future cycles. The company’s plan calls for continued execution through 2027 as it builds a foundation for growth in AI infrastructure-related markets.
Segment Sales and Earnings Profile
The presentation also lists year-end free-cash-flow conversion at 7% and year-end net leverage at 4.7x. Trailing-twelve-month free-cash-flow conversion was approximately 30% through June 30, 2026.
2027 Pathway Targets AI Infrastructure Growth
Chemours plans to pursue concentrated growth in liquid cooling, data centers, semiconductors and other AI infrastructure end markets. Pricing and cost improvements are intended to drive Titanium Technologies to a $400M mid-cycle adjusted EBITDA floor without a significant change in volumes. Advanced Performance Materials is targeting organic growth as Performance Solutions increases its existing 40%+ concentration in emerging AI infrastructure markets. The presentation shows 2025 adjusted EBITDA of $742M and an adjusted EBITDA figure of +$1B. It also says forward-looking statements are not guarantees and remain subject to risks including environmental liabilities, regulatory proceedings, litigation, supply-chain disruptions and changes in demand.
FAQs
Q: What is Chemours’ net leverage target?
A: Chemours is targeting net leverage below 3.0x through future cycles. The presentation lists second-quarter 2026 net leverage at 4.4x and links the plan to earnings growth and gross debt reduction.
Q: How is Chemours pursuing AI infrastructure growth?
A: Chemours is targeting liquid cooling, data centers, semiconductors and related AI infrastructure markets. Advanced Performance Materials is increasing Performance Solutions’ existing 40%+ concentration in emerging AI infrastructure end markets.
Q: What adjusted EBITDA figure did Chemours present?
A: The presentation shows 2025 adjusted EBITDA of $742M and an adjusted EBITDA figure of +$1B. The presentation also identifies a $400M mid-cycle adjusted EBITDA floor for Titanium Technologies.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.